Notably, luteolin (−6.07 kcal/mol) and β-carotene (−5.42 kcal/mol) demonstrated higher binding affinity, suggesting that BYHWD may exert therapeutic effects in AKI by modulating VEGFA-mediated angiogenesis and microcirculatory repair mechanisms. Here, VEGFA is linked to acute kidney injury.